P2Y12 inhibition in patients with NSTEMI--can later be better?
P2Y12 inhibition in patients with NSTEMI--can later be better?
复制标题
NSTEMI 患者的 P2Y12 抑制——以后会更好吗?
DOI:
10.1056/nejme1308820
复制
发表时间:
2013
期刊:
影响因子:
--
通讯作者:
KeaneyJr,JohnF
中科院分区:
文献类型:
--
作者:
KeaneyJr,JohnF
Acute coronary syndrome is an umbrella term that is used to describe the abrupt reduction of blood flow to myocardial tissue, typically associated with the rupture of a coronary atherosclerotic plaque. Rupture exposes the blood to plaque contents, resulting in the deposition and activation of platelets and the formation of thrombi. Complete thrombotic occlusion produces ST-segment elevation myocardial infarction, whereas incomplete impairment of coronary blood flow results in unstable angina or, when biomarkers for myocardial injury are present, non–ST-segment elevation myocardial infarction (NSTEMI). Because the rupture of a plaque incites platelet activation and thrombosis, treatments for unstable angina and NSTEMI . . .